Kevin Herde - 31 Oct 2022 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Chief Financial Officer
Signature
/s/ Kurt Oreshack, by power of attorney for Kevin Herde
Issuer symbol
MRVI
Transactions as of
31 Oct 2022
Net transactions value
+$6,745
Form type
4
Filing time
09 Nov 2022, 16:35:47 UTC
Previous filing
27 Jun 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $6,745 +478 +2.3% $14.11 21,294 31 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 478 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.